26 Variants of a Vaccine Against the Coronavirus are Being Developed in Russia

17 July 2020

GMP News

Currently 26 variants of a vaccine against the coronavirus infection are being developed in Russia and the research results give assurance that their use will begin in the near future, Russian Deputy Prime Minister Tatyana Golikova reported on Wednesday.

As of today, according to the plan approved by the government 26 vaccine variants are being developed. <…> the research results <…> give rise to our confidence that already in the near future several effective vaccines at once will be used,” she said at a meeting of the anti-coronavirus coordinating council.

Golikova also expressed hope that the coronavirus vaccine of the Vector Center soon will obtain the permission to conduct clinical trials.

On July 14, the Russian Ministry of Health received from the Vector State Research Center of Virology and Biotechnology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing the request for a permission to begin clinical trials of a vaccine against the novel coronavirus. According to Center’s General Director Rinat Maksyutov, registration of the first vaccine product is planned as early as the fall of this year.

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more